Anders Bjartell
181 – 190 of 372
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
The prostate cancer registry : Patient characteristics, treatments and preliminary outcomes from a large observational study of metastatic castration-resistant prostate cancer (mCRPC)
- Contribution to journal › Article
-
Mark
The Molecular Evolution of Castration-resistant Prostate Cancer
- Contribution to journal › Scientific review
-
Mark
Re : The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer
- Contribution to journal › Debate/Note/Editorial
- 2015
-
Mark
Re: Activity and Safety of ODM-201 in Patients with Progressive Metastatic Castration-resistant Prostate Cancer (ARADES): An Open-label Phase 1 Dose-escalation and Randomised Phase 2 Dose Expansion Trial
- Contribution to journal › Debate/Note/Editorial
-
Mark
Re: AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- Contribution to journal › Debate/Note/Editorial
-
Mark
miR-183 in Prostate Cancer Cells Positively Regulates Synthesis and Serum Levels of Prostate-specific Antigen.
- Contribution to journal › Article
-
Mark
miR-145 suppress the androgen receptor in prostate cancer cells and correlates to prostate cancer prognosis.
- Contribution to journal › Article
-
Mark
Short-term Results after Robot-assisted Laparoscopic Radical Prostatectomy Compared to Open Radical Prostatectomy.
- Contribution to journal › Article
-
Mark
Genomic Predictors of Outcome in Prostate Cancer.
- Contribution to journal › Scientific review
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
- Contribution to journal › Article
